sb 203580 has been researched along with Bone Neoplasms in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (25.00) | 29.6817 |
| 2010's | 8 (66.67) | 24.3611 |
| 2020's | 1 (8.33) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, J; Chen, X; Chu, L; Ding, Z; Guo, T; Hou, R; Huang, Z; Liang, H; Liang, J; Liao, J; Liu, S; Song, S; Tan, X; Wang, Y; Wen, J; Wu, Y; Yang, C; Zhang, B; Zhang, J; Zhang, Z | 1 |
| Chang, SL; Fong, YC; Hsu, CJ; Lin, CY; Tang, CH | 1 |
| Chen, J; Gong, L; Song, Y; Su, H; Yang, J; Zhang, Y; Zhao, P | 1 |
| Gweon, EJ; Kim, SJ | 1 |
| Ding, L; Jiang, T; Li, R; Wang, Z; Yang, Y; Zhang, S | 1 |
| Hou, M; Shi, Q; Wang, H; Weng, Y; Yan, S; Yao, J; Zuo, G | 1 |
| Babo, I; Harisi, R; Jeney, A; Kenessey, I; Olah, JN; Paku, S; Pogany, G; Timar, F | 1 |
| Kondo, A; Matsuda, T; Togari, A; Tsunashima, Y | 1 |
| Jiang, M; Li, C; Li, W; Liu, L; Liu, S; Ma, Z; Qiu, Q; Ren, C; Wang, L; Yang, J; Zhou, J | 1 |
| Chen, H; Fang, ZP; Kung, HF; Lin, MC; Min, DL; Shen, Z; Tang, LN; Yao, Y; Yu, WX; Yue, L | 1 |
| Eliazer, S; Ilaria, RL; Silvany, RE; Wolff, NC | 1 |
| Gutkind, JS; Sanchez-Arevalo, VJ; Sanchez-Prieto, R; Servitja, JM | 1 |
12 other study(ies) available for sb 203580 and Bone Neoplasms
| Article | Year |
|---|---|
H19 Promotes HCC Bone Metastasis Through Reducing Osteoprotegerin Expression in a Protein Phosphatase 1 Catalytic Subunit Alpha/p38 Mitogen-Activated Protein Kinase-Dependent Manner and Sponging microRNA 200b-3p.
Topics: Animals; Bone Neoplasms; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Movement; Disease Models, Animal; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; Humans; Imidazoles; Liver Neoplasms; Male; Mice; MicroRNAs; Osteoprotegerin; p38 Mitogen-Activated Protein Kinases; Protein Phosphatase 1; Pyridines; RAW 264.7 Cells; RNA, Long Noncoding; Up-Regulation; Zinc Finger E-box-Binding Homeobox 1 | 2021 |
Apoptosis signal-regulating kinase 1 is involved in brain-derived neurotrophic factor (BDNF)-enhanced cell motility and matrix metalloproteinase 1 expression in human chondrosarcoma cells.
Topics: Anthracenes; Bone Neoplasms; Brain-Derived Neurotrophic Factor; Carbazoles; Cell Line, Tumor; Cell Movement; Chondrosarcoma; Humans; Imidazoles; Indole Alkaloids; JNK Mitogen-Activated Protein Kinases; MAP Kinase Kinase Kinase 5; Matrix Metalloproteinase 1; Neoplasm Invasiveness; Neoplasm Metastasis; p38 Mitogen-Activated Protein Kinases; Prognosis; Protein Kinases; Pyridines; Receptor, trkB; Signal Transduction; Thioredoxins; Up-Regulation | 2013 |
The up-regulation of cysteine-rich protein 61 induced by transforming growth factor beta enhances osteosarcoma cell migration.
Topics: Adolescent; Adult; Bone Neoplasms; Cell Line, Tumor; Cell Movement; Child; Cysteine-Rich Protein 61; Enzyme Inhibitors; Female; Humans; Imidazoles; Male; Neoplasm Metastasis; Osteosarcoma; p38 Mitogen-Activated Protein Kinases; Pyridines; RNA Interference; RNA, Small Interfering; Signal Transduction; Transforming Growth Factor beta; Up-Regulation; Young Adult | 2013 |
Resveratrol attenuates matrix metalloproteinase-9 and -2-regulated differentiation of HTB94 chondrosarcoma cells through the p38 kinase and JNK pathways.
Topics: Anthracenes; Antineoplastic Agents, Phytogenic; Bone Neoplasms; Cell Differentiation; Cell Line, Tumor; Chondrosarcoma; Gene Expression Regulation, Neoplastic; Humans; Imidazoles; MAP Kinase Signaling System; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Pyridines; Resveratrol; Stilbenes | 2014 |
Effects of icariin on the regulation of the OPG-RANKL-RANK system are mediated through the MAPK pathways in IL-1β-stimulated human SW1353 chondrosarcoma cells.
Topics: Blotting, Western; Bone Neoplasms; Cell Line, Tumor; Cell Survival; Chondrosarcoma; Dose-Response Relationship, Drug; Drugs, Chinese Herbal; Enzyme Inhibitors; Enzyme-Linked Immunosorbent Assay; Flavonoids; Gene Expression Regulation, Neoplastic; Humans; Imidazoles; Interleukin-1beta; MAP Kinase Signaling System; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Osteoprotegerin; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Pyridines; RANK Ligand; Receptor Activator of Nuclear Factor-kappa B; Reverse Transcriptase Polymerase Chain Reaction | 2014 |
NOV inhibits proliferation while promoting apoptosis and migration in osteosarcoma cell lines through p38/MAPK and JNK/MAPK pathways.
Topics: Anthracenes; Apoptosis; Bone Neoplasms; Cell Line, Tumor; Cell Movement; Cell Proliferation; Humans; Imidazoles; JNK Mitogen-Activated Protein Kinases; MAP Kinase Signaling System; Nephroblastoma Overexpressed Protein; Osteosarcoma; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Pyridines | 2015 |
Differential inhibition of single and cluster type tumor cell migration.
Topics: Adolescent; Bone Neoplasms; Cell Culture Techniques; Cell Movement; Cell Proliferation; Chromones; Deoxyuridine; Enzyme Inhibitors; Extracellular Signal-Regulated MAP Kinases; Fibrosarcoma; Flavonoids; Humans; Imidazoles; Male; Morpholines; Okadaic Acid; Osteosarcoma; p38 Mitogen-Activated Protein Kinases; Paclitaxel; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Pyridines; Signal Transduction; Tumor Cells, Cultured | 2009 |
Inhibitory effect of vitamin K(2) on interleukin-1beta-stimulated proliferation of human osteoblasts.
Topics: Adult; Anticoagulants; Bone Neoplasms; Cell Line; Cell Proliferation; Cyclooxygenase 2; Cyclooxygenase Inhibitors; Dinoprostone; Enzyme Inhibitors; Flavonoids; Glutamic Acid; Humans; Imidazoles; Interleukin-1; Interleukin-1beta; Male; Mitogen-Activated Protein Kinase Kinases; Nitrobenzenes; Osteoblasts; Osteocalcin; Osteosarcoma; p38 Mitogen-Activated Protein Kinases; Pregnane X Receptor; Protein Kinase Inhibitors; Pyridines; Receptors, Steroid; Reverse Transcriptase Polymerase Chain Reaction; Rifampin; RNA, Messenger; Sulfonamides; Vitamin K; Vitamins; Warfarin; Young Adult | 2010 |
Tibia tumor-induced cancer pain involves spinal p38 mitogen-activated protein kinase activation via TLR4-dependent mechanisms.
Topics: Animals; Blotting, Western; Bone Neoplasms; Carcinoma 256, Walker; Enzyme Activation; Enzyme Inhibitors; Female; Imidazoles; Immunohistochemistry; Injections, Spinal; Interleukin-1beta; Neoplasm Transplantation; p38 Mitogen-Activated Protein Kinases; Pain, Intractable; Physical Stimulation; Pyridines; Radiography; Rats; Rats, Sprague-Dawley; Reverse Transcriptase Polymerase Chain Reaction; RNA, Small Interfering; Spinal Cord; Tibia; Toll-Like Receptor 4; Tumor Necrosis Factor-alpha | 2010 |
HGFK1 inhibits bone metastasis in breast cancer through the TAK1/p38 MAPK signaling pathway.
Topics: Adult; Aged; Animals; Bone Neoplasms; Breast Neoplasms; Cell Line, Tumor; Cell Movement; Dependovirus; Drug Screening Assays, Antitumor; Enzyme Activation; Female; Gene Expression Regulation, Neoplastic; Genes, Tumor Suppressor; Genetic Therapy; Genetic Vectors; Hepatocyte Growth Factor; Humans; Imidazoles; Intracellular Signaling Peptides and Proteins; Kringles; MAP Kinase Kinase Kinases; MAP Kinase Signaling System; Mice; Mice, Inbred BALB C; Middle Aged; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Prognosis; Protein Serine-Threonine Kinases; Pyridines; Real-Time Polymerase Chain Reaction; Receptor Activator of Nuclear Factor-kappa B | 2012 |
Interference with the constitutive activation of ERK1 and ERK2 impairs EWS/FLI-1-dependent transformation.
Topics: 3T3 Cells; Animals; Binding Sites; Bone Neoplasms; Butadienes; Cell Transformation, Neoplastic; Colony-Forming Units Assay; DNA; Enzyme Activation; Enzyme Inhibitors; Flavonoids; Genes, ras; Humans; Imidazoles; MAP Kinase Kinase 1; Mice; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinase Kinases; Mitogen-Activated Protein Kinases; Mutation; Nitriles; Oncogene Proteins, Fusion; Protein Serine-Threonine Kinases; Proto-Oncogene Protein c-fli-1; Pyridines; RNA-Binding Protein EWS; Sarcoma, Ewing; Transcription Factors; Tumor Cells, Cultured | 2000 |
Regulation of p73 by c-Abl through the p38 MAP kinase pathway.
Topics: Bone Neoplasms; Calcium-Calmodulin-Dependent Protein Kinases; Cell Line; DNA-Binding Proteins; Enzyme Activation; Enzyme Inhibitors; Epithelial Cells; Genes, abl; Genes, Tumor Suppressor; Humans; Imidazoles; JNK Mitogen-Activated Protein Kinases; Kidney; MAP Kinase Kinase 1; MAP Kinase Kinase 6; MAP Kinase Kinase 7; MAP Kinase Signaling System; Mitogen-Activated Protein Kinase Kinases; Mitogen-Activated Protein Kinases; Multigene Family; Nuclear Proteins; Osteosarcoma; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Phosphoserine; Phosphotyrosine; Proline; Protein Processing, Post-Translational; Protein Serine-Threonine Kinases; Protein-Tyrosine Kinases; Proto-Oncogene Proteins c-abl; Pyridines; Recombinant Fusion Proteins; src Homology Domains; Transcription, Genetic; Transfection; Tumor Cells, Cultured; Tumor Protein p73; Tumor Suppressor Proteins | 2002 |